Steve Lisi has served on our Board since January 2017. Mr. Lisi was previously Senior Vice President of Business and Corporate Development at Avadel Pharmaceuticals (AVDL) where he was instrumental in restructuring the company, raising over $125M, and transforming it from a $100 million enterprise value to $1 billion in 3 years.
Prior to his position at Avadel, Mr. Lisi spent 18 years investing in the global healthcare industry at Deerfield Management, Millennium Management, and SAC Capital, among others. Mr. Lisi serves as Chairman of the Board of Beyond Cancer, a nitric oxide based immuno-oncology company targeting solid tumors. He received his master’s degree in International Business from Pepperdine University.